Related Experiment Video
Updated: May 30, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Stem cell-based immunomodulation in type 1 diabetes: beyond the regenerative approach.
Biancamaria Longoni1, Franco Mosca
1Department of Oncology, Transplantation and New Technologies in Medicine, University of Pisa, Ospedale Cisanello, Via Paradisa, 2, Pisa, Italy. biancamaria.longoni@med.unipi.it
Current Pharmaceutical Design
|August 26, 2011
Summary
Stem cells offer new hope for Type 1 diabetes (T1D) treatment by generating insulin-producing beta cells for transplantation. Research also explores their potential to improve islet transplant success and manage immune responses in T1D patients.
Area of Science:
- Endocrinology
- Immunology
- Regenerative Medicine
Background:
- Type 1 diabetes (T1D) involves autoimmune destruction of pancreatic beta cells, leading to poor glycaemic control.
- While insulin therapy manages immediate metabolic issues, long-term complications like kidney failure persist.
- Islet transplantation improves glucose homeostasis but requires sufficient engraftment and faces immune challenges.
Purpose of the Study:
- To review the use of stem cells for generating beta cells for Type 1 diabetes islet transplantation.
- To highlight the need for enhanced protocols for stem cell-derived beta cell derivation and maturation.
- To explore the role of adult stem/progenitor cells in improving islet transplant viability and immune tolerance.
Main Methods:
- Review of current research on stem cell differentiation into functional beta cells.
- Analysis of studies investigating stem cell effects on islet graft survival and immune modulation.
- Examination of evidence for stem cell applications beyond beta cell regeneration in T1D.
Main Results:
- Stem cells show promise for generating beta cells for Type 1 diabetes treatment.
- Improved protocols are needed for efficient derivation and full maturation of stem cell-derived beta cells.
- Adult stem/progenitor cells may enhance islet transplantation by boosting graft viability and controlling immune responses.
Conclusions:
- Stem cell-based approaches are advancing Type 1 diabetes therapeutics.
- Further research is crucial to optimize stem cell differentiation and maturation for clinical islet transplantation.
- Stem cells present a dual therapeutic potential in Type 1 diabetes, encompassing both beta cell regeneration and immune modulation to support transplanted islets.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...